(Q73527459)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

W J Pan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L E Gustavson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Achari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M J Rieser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

X Ye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Gutterman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B A Wallin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Clinical Pharmacology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

316-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Clinical pharmacokinetics of pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

The use of high-flow high performance liquid chromatography coupled with positive and negative ion electrospray tandem mass spectrometry for quantitative bioanalysis via direct injection of the plasma/serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008874

10.1177/00912700022008874

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10709162%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference